Anti-doping analysis and the Olympics
The webinar started by reflecting on the London 2012 Olympic games, before moving on to highlight the technical and strategic challenges facing anti-doping analysts today.
The issues surrounding harmonization of standards and methods without stifling innovation were discussed, along with quality control and the importance of strong relationships with industry to anticipate and prepare for new doping trends.
The webinar was presented by Dr Olivier Rabin and Dr Patrick Schamasch, who together guest edited the July 2012 special issue of Bioanalysis dedicated to anti-doping analysis and the Olympics.
A live Q&A session followed the presentations, offering the audience the chance to pose questions to our expert speakers.
Topics Covered:
- London 2012 Olympic games
- Technical and strategic challenges in anti-doping
- Harmonization of standards and methods
- Innovation in anti-doping
- Quality control
- Industry input to anti-doping.
Who attended:
Senior directors, directors, clinicians, principal scientists, principal investigators, managers, project/team leaders in:
- Anti-doping analysis
- Sports science
- Bioanalysis
- Therapeutic drug monitoring
- Forensic analysis
- Drug discovery and development
- (Pre)clinical development
- Pharmacovigilance
- Safety testing.
Panelist biographies
Dr Olivier Rabin (Science Director, WADA)
Dr Rabin has extensive experience in pharmacology and toxicology, having worked at the NIH and the Institut National de la Santé et de la Recherche Médicale in France. He is currently involved with multiple collaborations with industry partners and oversees the certification of laboratory accreditation for anti-doping testing.
Dr Patrick Schamasch
Dr Schamasch is the Medical and Scientific Director for the International Olympic Committee (Lausanne, Switzerland) and the representative of IOC at the International Federation of Sports Medicine.
Sports drug testing involves the process of collecting a biological sample (i.e., blood, saliva or urine), which is then analyzed for chemicals that are banned or illegal in a sport. In competitive sports, certain performance-enhancing drugs are banned and in-competition testing is conducted to analyze an athlete’s biological profile.